ZA200705179B - Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide - Google Patents

Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide

Info

Publication number
ZA200705179B
ZA200705179B ZA200705179A ZA200705179A ZA200705179B ZA 200705179 B ZA200705179 B ZA 200705179B ZA 200705179 A ZA200705179 A ZA 200705179A ZA 200705179 A ZA200705179 A ZA 200705179A ZA 200705179 B ZA200705179 B ZA 200705179B
Authority
ZA
South Africa
Prior art keywords
beta
immunogenic compositions
peptides derived
cyclic peptides
amyloid peptide
Prior art date
Application number
ZA200705179A
Other languages
English (en)
Inventor
Zurbriggen Rinaldo
Original Assignee
Pevion Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pevion Biotech Ltd filed Critical Pevion Biotech Ltd
Publication of ZA200705179B publication Critical patent/ZA200705179B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA200705179A 2004-12-30 2007-06-26 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide ZA200705179B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04031023A EP1676859A1 (de) 2004-12-30 2004-12-30 Immunogene Zusammensetzungen aus zyklischen Peptiden abgegleitet vom beta-Amyloid Peptid

Publications (1)

Publication Number Publication Date
ZA200705179B true ZA200705179B (en) 2008-08-27

Family

ID=34928060

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705179A ZA200705179B (en) 2004-12-30 2007-06-26 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide

Country Status (7)

Country Link
US (1) US20080107649A1 (de)
EP (2) EP1676859A1 (de)
AU (1) AU2005321495A1 (de)
CA (1) CA2592690A1 (de)
EA (1) EA010586B1 (de)
WO (1) WO2006069718A1 (de)
ZA (1) ZA200705179B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
CN101506236B (zh) 2005-11-30 2012-12-12 雅培制药有限公司 抗淀粉样β蛋白的单克隆抗体及其用途
CN101330923B (zh) * 2005-12-12 2015-01-07 Ac免疫有限公司 治疗性疫苗
WO2007120834A2 (en) 2006-04-13 2007-10-25 Peptimmune, Inc. Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
EP2046822B1 (de) * 2006-07-12 2012-01-04 Agency for Science, Technology and Research Molekulare sonde für sphingolipide
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (de) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Verfahren zur Behandlung von Amyloidosen
AU2008287530A1 (en) * 2007-05-07 2009-02-19 Peptimmune, Inc. Methods for the directed expansion of epitopes for use as antibody ligands
BRPI0817682A2 (pt) 2007-10-16 2015-04-07 Peptimmune Inc Métodos para projetar e preparar vacinas compreendendo composições de polímero de sequência direcionada via a expansão direta de epítopos
EP2106802A1 (de) * 2008-04-02 2009-10-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Modifizierte Peptide als synthetische Impfungen bei Amyloid-bedingten Krankheiten
CA2759118A1 (en) 2008-04-17 2009-10-22 Declion Pharmaceuticals, Inc. Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
WO2010002251A1 (en) * 2008-07-01 2010-01-07 De Staat Der Nederlanden, Vert. Door De Minister Van Vws Vaccine against amyloid folding intermediate
MX2011000975A (es) * 2008-07-25 2011-05-25 Abbott Lab Analogos de peptido b amiloide, oligomeros de los mismos, procedimientos para preparar y composiciones que comprenden dichos analogos u oligomeros, y sus usos.
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
US20120016598A1 (en) * 2010-05-21 2012-01-19 Bruker Daltonik Gmbh Normalization of mass spectra acquired by mass spectrometric imaging
US9364449B2 (en) 2010-06-09 2016-06-14 New York University Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
JP6147665B2 (ja) 2010-08-14 2017-06-14 アッヴィ・インコーポレイテッド アミロイドベータ結合タンパク質
US20120089291A1 (en) * 2010-10-12 2012-04-12 Halder Bibhrajit Autonomous machine control system
WO2017079835A1 (en) 2015-11-09 2017-05-18 The University Of British Columbia Amyloid beta epitopes and antibodies thereto
EP3374379A4 (de) * 2015-11-09 2019-05-15 The University Of British Columbia N-terminale epitope in amyloid-beta und konformationsselektive antikörper dagegen
US10774120B2 (en) 2015-11-09 2020-09-15 The University Of British Columbia Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
US20180125920A1 (en) 2016-11-09 2018-05-10 The University Of British Columbia Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
IL296322A (en) 2020-03-10 2022-11-01 Lifearc Cyclic peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10101430B4 (de) * 2001-01-13 2008-10-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Lösliche cyclische Analoga zur Modulation der Amyloidogenese

Also Published As

Publication number Publication date
CA2592690A1 (en) 2006-07-06
US20080107649A1 (en) 2008-05-08
EA200701305A1 (ru) 2007-12-28
WO2006069718A1 (en) 2006-07-06
EP1831251A1 (de) 2007-09-12
EA010586B1 (ru) 2008-10-30
AU2005321495A1 (en) 2006-07-06
EP1676859A1 (de) 2006-07-05
WO2006069718A9 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
ZA200705179B (en) Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide
PL1817048T3 (pl) Stabilne preparaty peptydów insulinotropowych
PL1633391T3 (pl) Stabilizowane farmaceutycznie kompozycje peptydowe
EP1768698A4 (de) Immunogene zusammensetzungen mit hmgb1-polypeptiden
ZA200709239B (en) Compositions for administering RNAIII-inhibiting peptides
IL186959A0 (en) Peptides and pharmaceutical compositions containing the same
GB0323965D0 (en) Immunogenic compositions
ZA200602948B (en) Immunogenic compositions
ZA200705943B (en) Survivin peptide vaccine
IL177143A0 (en) Compositions, methods and uses for a novel family of peptides
AU2003902743A0 (en) Process for the preparation of cyclic peptides
EP1890720A4 (de) Pharmazeutische zusammensetzungen mit von casein stammenden peptiden und anwendungsverfahren dafür
EP1585503A4 (de) Verbesserte orale verabreichung von peptiden
IL186376A0 (en) Bone cement compositions and the like comprising an rnaiii-inhibiting peptide
IL184609A0 (en) Compositions containing an antigen and an adjuvent peptide
GB0426154D0 (en) IGF-1 novel peptides
IL173272A0 (en) Preparation of somatostatin peptides
EP1578787A4 (de) Neue chi-conotoxinpeptide (-ii)
HK1089776A1 (en) Pharmaceutical composition comprising cyclic somatostatin analogues
AU2003228863A8 (en) Immunogenic peptides
SI1787653T1 (sl) Protitumorski farmacevtski sestavek, ki vsebuje polipeptidne fragmente seralizinov
WO2007110772A8 (en) Immunomodulating oligopeptides
ZA200509741B (en) Pharmaceutical composition comprising cyclic smatostin analogues
ZA200710374B (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
HK1087630A1 (en) Subcutaneously-administered ganglioside-based vaccine compositions